Rendig Stephen V, Symons J David, Amsterdam Ezra A
Department of Internal Medicine, University of California, Davis 95616, USA.
Can J Physiol Pharmacol. 2003 Nov;81(11):1064-71. doi: 10.1139/y03-105.
This study tested the hypotheses that (i) lipophilic statins (atorvastatin and simvastatin) impair ventricular recovery from myocardial ischemia-reperfusion, owing to their greater myocyte permeability, compared with a hydrophilic statin (pravastatin), and (ii) statins enhance endothelium-dependent vasodilation of isolated coronary arteries from the ischemic region. Farm pigs consumed chow supplemented with atorvastatin (2.5 mg.kg(-1).d(-1); n=6), pravastatin (10 (n=3) or 20 (n=2) mg.kg(-1).d(-1)), simvastatin (5 mg.kg(-1).d(-1); n=6), or no statin (control; n=6) for 3 weeks. Animals were anesthetized and instrumented to measure regional (% segment shortening) and global (dP/dt max) left ventricular (LV) function during coronary artery occlusion (10 min) and reperfusion (30 min). Coronary resistance (i.d. = 119 +/- 3 microm) and conductance (i.d. = 487 +/- 11 microm) arteries were isolated from the ischemic region to measure receptor-dependent (acetylcholine (ACh)) and -independent (KCl) vasoconstriction, and endothelium-dependent (bradykinin (BK)) and -independent (sodium nitroprusside (SNP)) vasodilation. At 30 min reperfusion, neither percent recovery of regional ventricular function (atorvastatin, 24% +/- 15%; pravastatin, 36% +/- 13%; simvastatin, 29% +/- 13%; control, 36% +/- 13%) nor percent recovery of global LV cardiac function differed among groups. However, BK-induced vasorelaxation of coronary conductance vessels was greater (P<0.05) in statins versus controls, and ACh-induced vasoconstriction was less in simvastatin-treated animals, suggesting the potential for enhanced coronary arterial blood flow to the jeopardized region. In conclusion, our data suggest that ischemia-induced myocardial stunning is similar among pigs treated for 3 weeks with atorvastatin, pravastatin, or simvastatin, even though statin treatment appears to augment endothelium-dependent vasodilation of conductance, but not resistance, vessels subjected to ischemia-reperfusion.
(i)与亲水性他汀类药物(普伐他汀)相比,亲脂性他汀类药物(阿托伐他汀和辛伐他汀)因具有更高的心肌细胞通透性而损害心肌缺血再灌注后的心室恢复;(ii)他汀类药物可增强缺血区域离体冠状动脉的内皮依赖性血管舒张。家猪食用添加阿托伐他汀(2.5mg·kg⁻¹·d⁻¹;n = 6)、普伐他汀(10(n = 3)或20(n = 2)mg·kg⁻¹·d⁻¹)、辛伐他汀(5mg·kg⁻¹·d⁻¹;n = 6)或不添加他汀类药物(对照组;n = 6)的饲料,持续3周。对动物进行麻醉并安装仪器,以测量冠状动脉闭塞(10分钟)和再灌注(30分钟)期间局部(节段缩短百分比)和整体(最大dP/dt)左心室(LV)功能。从缺血区域分离冠状动脉阻力(内径 = 119±3微米)和传导(内径 = 487±11微米)动脉,以测量受体依赖性(乙酰胆碱(ACh))和非依赖性(氯化钾(KCl))血管收缩,以及内皮依赖性(缓激肽(BK))和非依赖性(硝普钠(SNP))血管舒张。在再灌注30分钟时,各组之间局部心室功能的恢复百分比(阿托伐他汀,24%±15%;普伐他汀,36%±13%;辛伐他汀,29%±13%;对照组,36%±13%)和整体左心室心功能的恢复百分比均无差异。然而,与对照组相比,他汀类药物组中BK诱导的冠状动脉传导血管舒张更大(P<0.05),且辛伐他汀治疗的动物中ACh诱导的血管收缩较小,这表明向受损区域增加冠状动脉血流量的可能性。总之,我们的数据表明,用阿托伐他汀、普伐他汀或辛伐他汀治疗3周的猪之间,缺血诱导的心肌顿抑相似,尽管他汀类药物治疗似乎增强了缺血再灌注的传导血管而非阻力血管的内皮依赖性血管舒张。